Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
lawgazette.co.uk4d
Bianca Castro
Our Privacy Policy has changed. Please click here to read about how we process your data in compliance with the General Data Protection Regulation (GDPR).